Jacob E. Berchuck, MD, is ann assistant professor in the Department of Hematology and Medical Oncology at Winship Cancer Institute of Emory University.
Epigenomic Platform Enhances Access to PSMA-Based Prostate Cancer Therapies
Jacob E. Berchuck, MD, discusses how a new epigenomic platform may influence the accessibility of PSMA-based therapies, especially for patients who may not have easy access to PSMA PET scans.
Liquid Biopsies Enhance PSMA-Directed Therapies in GU Cancers
Jacob E. Berchuck, MD, discusses the potential of liquid biopsies to enhance clinical decision-making regarding PSMA-directed therapies.
Epigenomic Liquid Biopsy for Detecting Tumor PSMA in Prostate Cancer
Jacob E. Berchuck, MD, discusses research behind using a blood-based liquid biopsy over traditional PSMA PET scans presented at the 2024 ESMO Congress.